Considering that a negative correlation between metformin and the metastatic spread of BC has been reported [48–50], we then assessed whether metformin may abolish the capability of insulin to induce a metastatic gene signature in BCAHC-1 cells. The gene discussed is INS; the disease is breast cancer.